Breast Cancer Trial, Recruiting (NCT05327543)

Breast Cancer Trial, Recruiting NCT05327543 Sponsor: Charite University, Berlin, Germany Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05327543 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with non-metastatic breast cancer (cancer that has not spread to other parts of the body, classified as stage I, II, or III), confirmed by a tissue test, within the last 5 years
People who finished their main cancer treatment at least 3 months ago
People whose quality of life is being affected by cancer, rated at least 4 out of 10 on a standard scale measuring this impact
People who are willing to take part in the study and have signed a consent form

Who may not be able to join:

People who are currently receiving or planning to receive chemotherapy, radiation therapy, or surgery
People with a serious physical condition, or a psychiatric condition that is being treated with medication, that would prevent them from taking part in the study
People who are pregnant or breastfeeding
People who are already taking part in another clinical trial involving behavioural, psychological, or complementary medicine approaches
People who have limited mobility or are unable to do gentle exercise due to a bone, nerve, or other medical condition
People who already meditate regularly more than twice a month
People who already practise yoga regularly more than twice a month

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05327543

Sponsor: Charite University, Berlin, Germany

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

More information: https://clinicaltrials.gov/study/NCT05327543

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with non-metastatic breast cancer (cancer that has not spread to other parts of the body, classified as stage I, II, or III), confirmed by a tissue test, within the last 5 years
People who finished their main cancer treatment at least 3 months ago
People whose quality of life is being affected by cancer, rated at least 4 out of 10 on a standard scale measuring this impact
People who are willing to take part in the study and have signed a consent form

Who may not be able to join:

People who are currently receiving or planning to receive chemotherapy, radiation therapy, or surgery
People with a serious physical condition, or a psychiatric condition that is being treated with medication, that would prevent them from taking part in the study
People who are pregnant or breastfeeding
People who are already taking part in another clinical trial involving behavioural, psychological, or complementary medicine approaches
People who have limited mobility or are unable to do gentle exercise due to a bone, nerve, or other medical condition
People who already meditate regularly more than twice a month
People who already practise yoga regularly more than twice a month

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Charite University, Berlin, Germany

Registry

ClinicalTrials.gov

Start date

9 May 2022

Est. completion

1 July 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov